Abstract
According to the World Health Organization, approximately 1.8–2.7 million people worldwide suffer from venomous snake bites each year and at least 138,000 of these incidents are fatal. Whereas, snakebite envenoming poses a serious threat to public health, yet the snake venom toxins endow several pharmacological effects, including presynaptic neurotoxicity, myotoxicity, and cardiotoxicity, as well as anticoagulant, hemolytic, hemorrhagic, edema-inducing, and platelet aggregation-inhibiting effects. Duplication and mutation of the genes encoding these toxins play an important role in generating molecular diversity. Curiously, venomous snakes are not lethal to the viper itself because the viper’s resistance against its own venom. However, endogenous inhibitor proteins evolutionarily acquired by venomous snakes to protect themselves have not yet been fully characterised because it is unclear how to inhibit for target toxin due to the lack of information including mutation analysis and the three-dimensional structures of the inhibitors. This review provides an overview of endogenous inhibitors of venomous snake as regulation systems for the toxin proteins. Recently, we isolated some inhibitors targeting different toxins from the sera of the Japanese vipers. We investigated the evolution of these endogenous inhibitors, which have been significantly influenced by positive selection. Directional mutagenesis, where mutation hotspots are found in genes encoding molecular surface proteins and functional domains of these proteins, acts as a diversifying mechanism for the exquisite biological targeting necessary to protect the host from its own venom.
Similar content being viewed by others
References
Aoki N, Deshimaru M, Kihara K, Terada S. Snake fetuin: isolation and structural analysis of new fetuin family proteins from the sera of venomous snakes. Toxicon. 2009;54(4):481–90. https://doi.org/10.1016/j.toxicon.2009.05.018.
Aoki N, Deshimaru M, Terada S. Active fragments of the antihemorrhagic protein HSF from serum of habu (Trimeresurus flavoviridis). Toxicon. 2007;49(5):653–62. https://doi.org/10.1016/j.toxicon.2006.11.001.
Aoki N, Matsuo H, Deshimaru M, Terada S. Accelerated evolution of small serum proteins (SSPs)—the PSP94 family proteins in a Japanese viper. Gene. 2008;426(1–2):7–14. https://doi.org/10.1016/j.gene.2008.08.021.
Aoki N, Sakiyama A, Deshimaru M, Terada S. Identification of novel serum proteins in a Japanese viper: homologs of mammalian PSP94. Biochem Biophys Res Commun. 2007;359(2):330–4. https://doi.org/10.1016/j.bbrc.2007.05.091.
Bastos VA, Gomes-Neto F, Perales J, Neves-Ferreira AG, Valente RH. Natural inhibitors of snake venom metalloendopeptidases: history and current challenges. Toxins. 2016. https://doi.org/10.3390/toxins8090250.
Campos PC, de Melo LA, Dias GLF, Fortes-Dias CL. Endogenous phospholipase A2 inhibitors in snakes: a brief overview. J Venom Anim Toxins Incl Trop Dis. 2016;22:37. https://doi.org/10.1186/s40409-016-0092-5.
Chijiwa T, Hamai S, Tsubouchi S, Ogawa T, Deshimaru M, Oda-Ueda N, et al. Interisland mutation of a novel phospholipase A2 from Trimeresurus flavoviridis venom and evolution of Crotalinae group II phospholipases A2. J Mol Evol. 2003;57(5):546–54. https://doi.org/10.1007/s00239-003-2508-4.
Clark WC, Voris HK. Venom neutralization by rattlesnake serum albumin. Science (New York, NY). 1969;164(3886):1402–4.
Domont GB, Perales J, Moussatché H. Natural anti-snake venom proteins. Toxicon. 1991;29(10):1183–94. https://doi.org/10.1016/0041-0101(91)90191-S.
Fontana F. Treatise on the venom of the viper; on the american poisons; and on the cherry laurel; and some other vegetable poisons. London: Forgotten Books; 1787.
Gutiérrez JM, Calvete JJ, Habib AG, Harrison RA, Williams DJ, Warrell DA. Snakebite envenoming. Nat Rev Dis Primers. 2017;3:17079. https://doi.org/10.1038/nrdp.2017.79.
Kasturiratne A, Wickremasinghe AR, de Silva N, Gunawardena NK, Pathmeswaran A, Premaratna R, et al. The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths. PLOS Med. 2008;5(11):e218. https://doi.org/10.1371/journal.pmed.0050218.
Koh CY, Kini RM. From snake venom toxins to therapeutics—cardiovascular examples. Toxicon. 2012;59(4):497–506. https://doi.org/10.1016/j.toxicon.2011.03.017.
Koh CY, Modahl CM, Kulkarni N, Kini RM. Toxins are an excellent source of therapeutic agents against cardiovascular diseases. Semin Thromb Hemost. 2018;44(07):691–706. https://doi.org/10.1055/s-0038-1661384.
Reeks T, Lavergne V, Sunagar K, Jones A, Undheim E, Dunstan N, et al. Deep venomics of the Pseudonaja genus reveals inter- and intra-specific variation. J Proteom. 2016;133:20–32. https://doi.org/10.1016/j.jprot.2015.11.019.
Shibata H, Chijiwa T, Oda-Ueda N, Nakamura H, Yamaguchi K, Hattori S, et al. The habu genome reveals accelerated evolution of venom protein genes. Sci Rep. 2018;8(1):11300. https://doi.org/10.1038/s41598-018-28749-4.
Shioi N, Deshimaru M, Terada S. Structural analysis and characterization of new small serum proteins from the serum of a venomous snake (Gloydius blomhoffii). Biosci Biotechnol Biochem. 2014;78(3):410–9. https://doi.org/10.1080/09168451.2014.890030.
Shioi N, Nishijima A, Terada S. Flavorase, a novel non-haemorrhagic metalloproteinase in Protobothrops flavoviridis venom, is a target molecule of small serum protein-3. J Biochem. 2015;158(1):37–48. https://doi.org/10.1093/jb/mvv017.
Shioi N, Ogawa E, Mizukami Y, Abe S, Hayashi R, Terada S. Small serum protein-1 changes the susceptibility of an apoptosis-inducing metalloproteinase HV1 to a metalloproteinase inhibitor in habu snake (Trimeresurus flavoviridis). J Biochem. 2013;153(1):121–9. https://doi.org/10.1093/jb/mvs127.
Shioi N, Tadokoro T, Shioi S, Okabe Y, Matsubara H, Kita S, et al. Crystal structure of the complex between venom toxin and serum inhibitor from viperidae snake. J Biol Chem. 2018. https://doi.org/10.1074/jbc.ra118.006840.
Tan KY, Tan CH, Fung SY, Tan NH. Venomics, lethality and neutralization of Naja kaouthia (monocled cobra) venoms from three different geographical regions of Southeast Asia. J Proteom. 2015;120:105–25. https://doi.org/10.1016/j.jprot.2015.02.012.
Tanaka Y, Oyama S, Hori S, Ushio K, Shioi N, Terada S, et al. Accelerated evolution of fetuin family proteins in Protobothrops flavoviridis (habu snake) serum and the discovery of an L1-like genomic element in the intronic sequence of a fetuin-encoding gene. Biosci Biotechnol Biochem. 2013;77(3):582–90. https://doi.org/10.1271/bbb.120829.
Valente RH, Dragulev B, Perales J, Fox JW, Domont GB. BJ46a, a snake venom metalloproteinase inhibitor Isolation, characterization, cloning and insights into its mechanism of action. Eur J Biochem. 2001;268(10):3042–52.
Waheed H, Moin SF, Choudhary MI. Snake venom: from deadly toxins to life-saving therapeutics. Curr Med Chem. 2017;24(17):1874–91. https://doi.org/10.2174/0929867324666170605091546.
Yamaguchi K, Chijiwa T, Yamamura T, Ikeda N, Yatsui T, Hayama S, et al. Interisland variegation of venom [Lys(49)]phospholipase A2 isozyme genes in Protobothrops genus snakes in the southwestern islands of Japan. Toxicon. 2015;107(Pt B):210–6. https://doi.org/10.1016/j.toxicon.2015.08.024.
Yamaguchi Y, Shimohigashi Y, Chijiwa T, Nakai M, Ogawa T, Hattori S, et al. Characterization, amino acid sequence and evolution of edema-inducing, basic phospholipase A2 from Trimeresurus flavoviridis venom. Toxicon. 2001;39(7):1069–76.
Yamakawa Y, Omori-Satoh T. Primary structure of the antihemorrhagic factor in serum of the Japanese Habu: a snake venom metalloproteinase inhibitor with a double-headed cystatin domain. J Biochem. 1992;112(5):583–9.
Acknowledgements
This work was supported in part by KAKENHI of Japan Society for the Promotion of Science (Nos. 16K18880 and 17KK0179) and the Naito Foundation of Japan (160605), and the Central Research Institute and the female researcher support programmed of Fukuoka University. We thank Japan Society for the Promotion of Science (JSPS), the Naito Foundation and Fukuoka University.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Aoki-Shioi, N. Adaptation and diversification of venomous snake proteins. Nucleus 62, 165–172 (2019). https://doi.org/10.1007/s13237-019-00270-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13237-019-00270-7